Ethosuximide-d3

• CAT Number: R010880
• CAS Number: 1189703-33-0
• Molecular Formula: C7H11NO2
• Molecular Weight: 144.19
• Purity: ≥95%
• Synonyms: 3-(Ethyl-d3)-3-methyl-2,5-pyrrolidinedione; 2-(Ethyl-d3)-2-methylsuccinimide; Atysmal-d3; Capitus-d3; Emeside-d3; Etosuximid-d3; H 940;-d3 Mesentol-d3; NSC 64013-d3; Simatin-d3; Succimal-d3; Succimitin-d3; Suxilep-d3; Suximal-d3
• Storage: Store at 4°C
• IUPAC Name: 3-methyl-3-(2,2,2-trideuterioethyl)pyrrolidine-2,5-dione
• InChI: InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)/i1D3
• InChIKey: HAPOVYFOVVWLRS-FIBGUPNXSA-N
• SMILES: [2H]C([2H])([2H])CC1(CC(=O)NC1=O)C

Ethosuximide-d3（Cat No.:R010880） is a deuterated form of Ethosuximide, a key anticonvulsant used to treat absence seizures, enriched with three deuterium atoms. This isotopic alteration significantly improves the stability and detectability of the compound during analytical procedures. Ethosuximide-d3 is crucial for metabolic and pharmacokinetic studies, providing enhanced resolution in mass spectrometry analyses. It is instrumental in tracing the drug’s absorption, distribution, metabolism, and excretion processes. By enabling precise and reliable experimental results, Ethosuximide-d3 supports advanced research into seizure management and therapeutic drug monitoring.